FDA Relying On Pedigree Info To Authorize Use Of Imported Flu Vaccine
This article was originally published in The Pink Sheet Daily
FDA is relying on confirmed lot numbers and pedigree information to authorize the use of Sanofi-Aventis' Fluzone purchased directly from European distributors by state and local governments
You may also be interested in...
Patients using GSK's Fluarix under IND will need to complete an informed consent form. HHS is immediately purchasing 1.2 mil doses of the influenza vaccine, with an option to procure up to 2.8 mil. additional doses.
FDA hopes that some or all of the excess foreign flu vaccine will be available for U.S. use by year-end, FDA Acting Commissioner Crawford tells Senate subcommittee. FDA should finish reviewing 750,000 doses of foreign vaccine purchased through distribution channels by cities and states in two to three weeks, Crawford says.
Italy claims to have pushed farther into managed entry agreements than other European countries with strong clawback provisions on new drugs – particularly cancer drugs – if they don't work as well as their manufacturers claim. The financial clawbacks are supported by extensive outcome data collection across the country's twenty regions.